SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-16-478386
Filing Date
2016-02-25
Accepted
2016-02-25 16:22:42
Documents
6
Effectiveness Date
2016-02-25

Document Format Files

Seq Description Document Type Size
1 S-3ASR d132555ds3asr.htm S-3ASR 262967
2 EX-5.1 d132555dex51.htm EX-5.1 14751
3 EX-12.1 d132555dex121.htm EX-12.1 16303
4 EX-23.1 d132555dex231.htm EX-23.1 1468
5 GRAPHIC g132555g44k41.jpg GRAPHIC 5818
6 GRAPHIC g132555g73o18.jpg GRAPHIC 7182
  Complete submission text file 0001193125-16-478386.txt   314956
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-209709 | Film No.: 161456246
SIC: 2834 Pharmaceutical Preparations